CCR6 and myeloid sarcoma: In MS patients, but not in controls, we observed a significant correlation between mean PM10 level in the previous 15 days and expression on CD4+ T cells of CCR6, a chemokine receptor characteristic of Th17 cells (Fig. 1 and Tables 1 and 2).